4//SEC Filing
Banerjee Sirshendu Roopom 4
Accession 0001062993-23-020809
CIK 0001907685other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:31 PM ET
Size
5.9 KB
Accession
0001062993-23-020809
Insider Transaction Report
Form 4
Banerjee Sirshendu Roopom
Director
Transactions
- Award
Stock Option (Right to Purchase)
2023-11-09+122,487→ 122,487 totalExercise: $0.32From: 2023-11-09Exp: 2033-11-09→ Common Stock (122,487 underlying)
Footnotes (2)
- [F1]Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The options were fully vested on the date of grant.
- [F2]In furtherance of the registrant's cash conservation efforts, the options were granted in lieu of the annual cash retainer and committee fees due to non-employee directors for the quarter ended September 30, 2023, in accordance with the registrant's February 2023 temporary modification to its non-employee director compensation plan. This option was issued to the reporting person in lieu of retainer fees of $16,250. For more information related to the registrant's non-employee director compensation plan and the February 2023 temporary modification, see the registrant's Annual Report on Form 10-K for the year ended December 31, 2022.
Issuer
Comera Life Sciences Holdings, Inc.
CIK 0001907685
Entity typeother
Related Parties
1- filerCIK 0001926535
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:31 PM ET
- Size
- 5.9 KB